Renal artery stenosis following renal denervation: A matter of concern

Journal of Hypertension

Volumn 32, Issue 10, 2014, Pages 2101-2105

  Persu, Alexandre ^a,b   Sapoval, Marc ^c,d   Azizi, Michel ^c,d   Monge, Matthieu ^d   Danse, Etienne ^b   Hammer, Frank ^b   Renkin, Jean ^a,b  

^a Institut de Recherches Expérimentales et Cliniques   (Belgium)

^b CLINIQUES UNIVERSITAIRES SAINT LUC   (Belgium)

^c UNIVERSITÉ PARIS DESCARTES   (France)

^d HÔPITAL EUROPÉEN GEORGES POMPIDOU   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANGIOPLASTY; BALLOON CATHETER; COMPUTED TOMOGRAPHIC ANGIOGRAPHY; DYSPNEA; ECHOCARDIOGRAPHY; HUMAN; HYPERTENSION; KIDNEY ARTERY STENOSIS; KIDNEY DENERVATION; KIDNEY DENERVATION SYSTEM; LETTER; LUNG EDEMA; MAGNETIC RESONANCE ANGIOGRAPHY; MITRAL VALVE REGURGITATION; NITINOL STENT; POLYURIA; PRIORITY JOURNAL; RADIOFREQUENCY ABLATION DEVICE; RANDOMIZED CONTROLLED TRIAL (TOPIC); RESISTANT HYPERTENSION; SELF EXPANDING STENT; SYSTOLIC BLOOD PRESSURE; TACHYCARDIA; TRANSCATHETER AORTIC VALVE IMPLANTATION;

EID: 84919712519     PISSN: 02636352     EISSN: 14735598     Source Type: Journal    
DOI: 10.1097/HJH.0000000000000323     Document Type: Letter

References (31)

1. Bhatt DL, Kandzari DE, O'Neill WW, D'Agostino R, Flack JM, Katzen BT, et al. The SYMPLICITY HTN-3 Investigators. Controlled Trial of Renal Denervation for Resistant Hyper-tension. N Engl J Med 2014; 370:1393-1401.
2. Böhm M, Mahfoud F, Ukena C, Bauer A, Fleck E, Hoppe UC, et al. Rationale and design of a large registry on renal denervation: the Global SYMPLICITY registry. EuroIntervention 2013; 9:484-492.
3. Krum H, Schlaich M, Whitbourn R, Sobotka PA, Sadowski J, Bartus K, et al. Catheter-based renal sympathetic denervation for resistant hypertension: a multicentre safety and proof-of-principle cohort study. Lancet 2009; 373:1275-1281.
4. Symplicity HTN-1 Investigators. Catheter-based renal sympathetic denervation for resistant hypertension. Durability of blood pressure reduction out to 24 months. Hypertension 2011; 57:911-917.
5. Davis MI, Filion KB, Zhang D, Eisenberg MJ, Afilalo J, Schiffrin EL, Joyal D. Effectiveness of renal denervation therapy for resistant hypertension: a systematic review and meta-analysis. J Am Coll Cardiol 2013; 62:231-241.
6. Symplicity HTN-2 Investigators. Renal sympathetic denervation in patients with treatment-resistant hypertension (The Symplicity HTN-2 Trial): a randomised controlled trial. Lancet 2010; 376:1903-1909.
7. Persu A, Renkin J, Thijs L, Staessen JA. Renal denervation: ultima ratio or standard in treatment-resistant hypertension. Hypertension 2012; 60:596-606.
8. Pellerin O, Sapoval M, Trinquart L, Redheuil A, Azarine A, Chatellier G, Mousseaux E. Accuracy of multidetector computed tomographic angiography assisted by postprocessing software for diagnosis atheromatous renal artery stenosis. Diagn Interv Imaging 2013; 94:1123-1131.
9. Hutchinson BD, Keane D, Dodd JD. Renal sympathetic denervation: MDCT evaluation of the renal arteries. AJR Am J Roentgenol 2013; 201:W342-346.
10. Holmes DR Jr, Monahan KH, Packer D. Pulmonary vein stenosis complicating ablation for atrial fibrillation: clinical spectrum and interventional considerations. JACC Cardiovasc Interv 2009; 2:267-276.
11. Templin C, Jaguszewski M, Ghadri JR, Sudano I, Gaehwiler R, Hellermann JP, et al. Vascular lesions induced by renal nerve ablation as assessed by optical coherence tomography: preand postprocedural comparison with the Simplicity( catheter system and the EnligHTN ( multielectrode renal denervation catheter. Eur Heart J 2013; 34:2141-2148.
12. Krum H, Schlaich MP, Sobotka PA, Böhm M, Mahfoud F, Rocha-Singh K, et al. Percutaneous renal denervation in patients with treatmentresistant hypertension: final 3-year report of the Symplicity HTN-1 study. Lancet 2014; 383:622-629.
13. Kaiser L, Beister T, Wiese A, von Wedel J, Meincke F, Kreidel F, et al. Results of the ALSTER BP real-world registry on renal denervation employing the Symplicity system. EuroIntervention 2014; 10:157-165.
14. Vonend O, Antoch G, Rump LC, Blondin D. Secondary rise in blood pressure after renal denervation. Lancet 2012; 380:778.
15. Kaltenbach B, Id D, Franke JC, Sievert H, Hennersdorf M, Maier J, Bertog SC. Renal artery stenosis after renal sympathetic denervation. J Am Coll Cardiol 2012; 60:2694-2695.
16. Bacaksiz A, Uyarel H, Jafarov P, Kucukbuzcu S. Iatrogenic renal artery stenosis after renal sympathetic denervation. Int J Cardiol 2014; 172:e389-e390.
17. Pucci G, Battista F, Lazzari L, Dominici M, Boschetti E, Schillaci G. Progression of renal artery stenosis after renal denervation. Circ J 2014; 78:767-768.
18. Versaci F, Trivisonno A, Olivieri C, Caranci F, Brunese L, Prati F. Late renal artery stenosis after renal denervation: Is it the tip of the iceberg? Int J Cardiol 2014; 172:e507-e508.
19. Jaén Águila FJ, Mediavilla Garc?á JD, Navarro EM, Vargas Hitos JA, Fernández-Torres C. Bilateral renal artery stenosis after renal denervation. Hypertension 2014; 63:e126-e127.
20. Versaci F, Trivisonno A, Olivieri C, Magri G, Caranci F, Prati F. Is an abnormal vascular response after renal sympathetic denervation predictive of permanent damage? An unusual case of late renal artery stenosis after energy delivery. J Endovasc Ther 2014; 21:191-196.
21. Raman B, Pathik B, Bridgman C. Recurrent pulmonary oedema after percutaneous radiofrequency renal denervation. Int J Cardiol 2014; 174:e42-e43.
22. http://www.tctmd.com/show.aspx?id113832. [Accessed 26 February 2014].
23. Worthley SG, Tsioufis CP, Worthley MI, Sinhal A, Chew DP, Meredith IT, et al. Safety and efficacy of a multielectrode renal sympathetic denervation system in resistant hypertension: the EnligHTN I trial. Eur Heart J 2013; 34:2132-2140.
24. Chandra AP, Marron CD, Puckridge P, Spark JI. Severe bilateral renal artery stenosis after transluminal radiofrequency ablation of renal sympathetic nerve plexus. J Vasc Surg 2014; [Epub ahead of print].
25. Mabin T, Sapoval M, Cabane V, Stemmett J, Iyer M. First experience with endovascular ultrasound renal denervation for the treatment of resistant hypertension. EuroIntervention 2012; 8:57-61.
26. http://www.tctmd.com/show.aspx?id120456. [Accessed 26 February 2014].
27. http://www.tctmd.com/txshow.aspx?tid208&id121514&trid198. [Accessed 26 February 2014].
28. Gilard M, Eltchaninoff H, Iung B, Donzeau-Gouge P, Chevreul K, Fajadet J, et al. FRANCE 2 Investigators. Registry of transcatheter aortic-valve implantation in high-risk patients. N Engl J Med 2012; 366:1705-1715.
29. Grube E, Sinning JM, Vahanian A. The Year in Cardiology 2013: valvular heart disease (focus on catheter-based interventions). Eur Heart J 2014; 35:490-495.
30. Crowley JJ1, Santos RM, Peter RH, Puma JA, Schwab SJ, Phillips HR, et al. Progression of renal artery stenosis in patients undergoing cardiac catheterization. Am Heart J 1998; 136:913-918.
31. Persu A, Jin Y, Azizi M, Baelen M, Völz S, Elvan A, et al. Blood pressure changes after renal denervation at 10 European expert centers. J Hum Hypertens 2014; 28:150-156.